MNI China Daily Summary: Monday, December 9

MNI BRIEF: China To Strengthen Policy Easing In 2025: Poliburo

MNI BRIEF: Japan Nov Sentiment, Outlook Indexes Rise

MNI BRIEF: China Nov CPI Slows To 5-Month Low Of 0.2% Y/Y

MNI: PBOC Sets Yuan Parity Higher At 7.1870 Mon; -1.39% Y/Y

MNI: China CFETS Yuan Index Down 0.36% In Week of Dec 6

MNI JAPAN Q3 GDP REV +0.3% Q/Q; PRELIM +0.2%; MEDIAN +0.2%

MNI: UNIV OF MICHIGAN CONSUMER SENTIMENT PRELIMINARY DEC INDEX 74.0

CANADA NOV IVEY PURCHASING MANAGERS INDEX 52.3 SA

MNI EXCLUSIVE: EU-Mercosur Deal Close, But Likely Short-Lived - Officials

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Pfizer (PFE: A2/A): Sale Of Haleon Shares

HEALTHCARE
Credit BulletsBulletHomepagemarkets-real-timeCredit
  • Small positive: Pfizer has raised £2.66bn by selling around 700m shares in Haleon
  • As part of the transaction, Haleon themselves have bought 60.5m shares from Pfizer for £230m, of which 30.1m will be cancelled.
  • Pfizer sold 640m shares into the market.
  • At the last filing, PFE owned 1,667,774,403 shares in Haleon (18.26%)
  • Pfizer's stake is now around 10.5% of Haleon.
56 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • Small positive: Pfizer has raised £2.66bn by selling around 700m shares in Haleon
  • As part of the transaction, Haleon themselves have bought 60.5m shares from Pfizer for £230m, of which 30.1m will be cancelled.
  • Pfizer sold 640m shares into the market.
  • At the last filing, PFE owned 1,667,774,403 shares in Haleon (18.26%)
  • Pfizer's stake is now around 10.5% of Haleon.